CVM.AMEXCel Sci CORP

DEF 14A: CEL-SCI Corp to Hold Annual Shareholder Meeting on April 19, 2024; Proposes New Stock Option Plan

Sentiment:

Proxy Statement


CEL-SCI Corporation announces its annual shareholder meeting to be held on April 19, 2024, including proposals to elect directors, adopt a new stock option plan, and ratify the appointment of its independent accounting firm.

Summary

  • CEL-SCI Corporation will hold its annual meeting of shareholders on April 19, 2024, at the Hilton McLean Tysons Corner in McLean, Virginia.
  • Shareholders will vote on the election of directors, the adoption of the 2024 Non-Qualified Stock Option Plan, and the ratification of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending September 30, 2024.
  • The record date for determining shareholders entitled to vote at the meeting was February 23, 2024, with 53,979,231 outstanding shares of common stock.
  • The Board of Directors is soliciting proxies and encourages shareholders to vote promptly.
  • The 2024 Non-Qualified Stock Option Plan authorizes the issuance of up to 2,000,000 shares of CEL-SCI's common stock.
  • As of February 23, 2024, no options had been granted under the 2024 Non-Qualified Stock Option Plan.
  • The Board of Directors recommends voting in favor of all proposals.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The extension of executive employment agreements and the proposed stock option plan suggest a degree of confidence in the company's future, contributing to a slightly positive sentiment.

Positives

  • The extension of employment agreements with key executives (Geert Kersten, Patricia Prichep, and Eyal Talor) through August 31, 2027, provides stability in leadership.
  • The proposed 2024 Non-Qualified Stock Option Plan aims to incentivize employees, directors, officers, consultants, and advisors.
  • The Audit Committee believes that the fees paid to BDO USA, P.C. are consistent with maintaining its independence.

Negatives

  • The document does not explicitly state any negative aspects, but the back salaries owed to employees may be a concern.
  • The company owed back salaries to Geert Kersten ($72,168), Patricia Prichep ($9,146), Eyal Talor, Ph.D. ($11,291), and John Cipriano ($7,866) as of September 30, 2023.

Risks

  • Failure to secure shareholder approval for the proposed 2024 Non-Qualified Stock Option Plan could impact the company's ability to attract and retain talent.
  • The potential payouts to executives upon certain termination events could represent a financial burden for the company.
  • The company's reliance on stock options as a key component of executive compensation may dilute shareholder value if not managed effectively.
  • The company's financial performance and stockholder value are influenced to a substantial degree by external factors.

Future Outlook

The company is focused on obtaining shareholder approval for the proposed 2024 Non-Qualified Stock Option Plan and continuing its operations under the guidance of its executive team.

Management Comments

  • The Board of Directors solicits the enclosed proxy.
  • Your vote is important no matter how large or small your holdings.
  • To assure your representation at the meeting, please vote promptly.

Industry Context

This announcement is typical for publicly traded companies as they prepare for their annual shareholder meetings. The proposals are standard governance matters, including director elections, auditor ratification, and executive compensation plans.

Comparison to Industry Standards

  • The structure of CEL-SCI's board and committees aligns with standard corporate governance practices for publicly listed companies.
  • The executive compensation packages, including base salaries, stock options, and benefits, are designed to be competitive within the biotechnology industry.
  • The audit fees paid to BDO USA, P.C. are within the range of what similar-sized companies pay for audit services.
  • The proposed 2024 Non-Qualified Stock Option Plan is a common tool used by companies to incentivize employees and align their interests with those of shareholders.

Stakeholder Impact

  • Shareholders will be impacted by the election of directors and the approval of the 2024 Non-Qualified Stock Option Plan.
  • Employees, directors, officers, consultants, and advisors are eligible to be granted options pursuant to the 2024 Non-Qualified Plan.
  • The ratification of BDO USA, P.C. as the independent auditor ensures the integrity of the company's financial reporting.

Next Steps

  • Shareholders need to review the proxy materials and vote on the proposals.
  • The company will hold its annual meeting on April 19, 2024.
  • The company will file a Form 8-K to report the final voting results within four business days after the Annual Meeting.

Key Dates

DateDescription
August 31, 2019CEL-SCI entered into four-year employment agreements with Geert Kersten, Patricia B. Prichep, and Eyal Talor, Ph.D.
September 30, 2023End of CEL-SCI's fiscal year.
October 26, 2023CEL-SCI agreed to extend Geert Kersten's employment agreement to August 31, 2027.
August 31, 2023CEL-SCI agreed to extend Patricia B. Prichep and Eyal Talor, Ph.D.'s employment agreements to August 31, 2027.
February 23, 2024Record date for determining shareholders entitled to notice of and to vote at the annual meeting.
April 4, 2024Deadline to request a paper copy of proxy materials to facilitate timely delivery.
April 19, 2024Date of the annual meeting of shareholders.
January 2, 2025Deadline for shareholder proposals to be received by the Secretary of CEL-SCI for inclusion in the proxy solicitation material for the following annual meeting.

Keywords

CEL-SCI, shareholders, proxy, directors, stock options, BDO USA, compensation, annual meeting, audit committee, executive compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.